2007
DOI: 10.1016/j.joen.2007.03.012
|View full text |Cite
|
Sign up to set email alerts
|

Tooth Slice–Based Models for the Study of Human Dental Pulp Angiogenesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
63
0
16

Year Published

2011
2011
2020
2020

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 73 publications
(85 citation statements)
references
References 30 publications
(28 reference statements)
3
63
0
16
Order By: Relevance
“…VegfA (vascular endothelial cell growth factor A), a Bmp2-regulated protein, is a key factor in angiogenesis and blood vessel formation in bone marrow osteoblasts and dental pulp region (Deckers et al, 2002;Gonçalves et al, 2007;Zhang et al, 2009;Maes et al, 2010b). Bmp2 has been shown to promote proliferation and migration of endothelial cells through the VegfA/VegfR2 signaling pathway (Suzuki et al, 2008).…”
Section: Tissue Preparation and Analysismentioning
confidence: 99%
“…VegfA (vascular endothelial cell growth factor A), a Bmp2-regulated protein, is a key factor in angiogenesis and blood vessel formation in bone marrow osteoblasts and dental pulp region (Deckers et al, 2002;Gonçalves et al, 2007;Zhang et al, 2009;Maes et al, 2010b). Bmp2 has been shown to promote proliferation and migration of endothelial cells through the VegfA/VegfR2 signaling pathway (Suzuki et al, 2008).…”
Section: Tissue Preparation and Analysismentioning
confidence: 99%
“…Several in vivo study models have been developed and conducted using many cell lines 1,2,36,38,40 . Synthetic and natural scaffolds have been developed and applied successfully 16,24,26 . Moreover, several techniques used in modern clinical dentistry emerged from the application of tissue engineering principles.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, its use in scaffolds may increase blood vessel anastomosis in addition to microvessel density, thereby providing proper nutrition for the establishment of the cell/scaffold assembly 16 . Mullane et al 17 tested different concentrations of VEGF and fibroblast growth factor-2 (FGF-2) and observed in vivo that, after fourteen days, the treatment with 50 ng/mL of VEGF was superior to the other groups and to the groups not treated with growth factors.…”
Section: Bioactive Moleculesmentioning
confidence: 99%
See 2 more Smart Citations